{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:26:18Z","timestamp":1792682778997,"version":"4.5.0"},"reference-count":114,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol Toxicol"],"DOI":"10.1186\/s40360-025-01039-2","type":"journal-article","created":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T14:24:34Z","timestamp":1765290274000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Innovative approach in Parkinson\u2019s targeting via berberine-loaded mucoadhesive surface-modified liposomes: a multi-faceted study"],"prefix":"10.1186","volume":"26","author":[{"given":"Hisham A.","family":"Nematalla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Elharoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad M.","family":"Abd-Alhaseeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hend A.","family":"Sharafeldin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manal A","family":"Elsheikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haidy","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amr","family":"Elkelish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Komla Mawunyo","family":"Dossouvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir E.","family":"Mehana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fathy Elsayed","family":"Abdelgawad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam","family":"Zewail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,9]]},"reference":[{"key":"1039_CR1","doi-asserted-by":"crossref","unstructured":"Cheng Z, Kang C, Che S, Su J, Sun Q, Ge T, Guo Y, Lv J, Sun Z, Yang W, Li B, Li X, Cui R. Berberine: a promising treatment for neurodegenerative diseases. Front Pharmacol. 2022;13:845591.","DOI":"10.3389\/fphar.2022.845591"},{"key":"1039_CR2","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, Bloem BR, Adler CH, Deuschl G. MDS clinical diagnostic criteria for parkinson\u2019s disease. Mov Disorders: Official J Mov Disorder Soc. 2015;30:1591\u2013601.","journal-title":"Mov Disorders: Official J Mov Disorder Soc"},{"key":"1039_CR3","doi-asserted-by":"publisher","first-page":"102357","DOI":"10.1016\/j.arr.2024.102357","volume":"99","author":"DG Gadhave","year":"2024","unstructured":"Gadhave DG, Sugandhi VV, Jha SK, Nangare SN, Gupta G, Singh SK, Dua K, Cho H, Hansbro PM, Paudel KR. Neurodegenerative disorders: mechanisms of degeneration and therapeutic approaches with their clinical relevance. Ageing Res Rev. 2024b;99:102357.","journal-title":"Ageing Res Rev"},{"key":"1039_CR4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40035-015-0042-0","volume":"4","author":"Q Wang","year":"2015","unstructured":"Wang Q, Liu Y, Zhou J. Neuroinflammation in parkinson\u2019s disease and its potential as therapeutic target. Translational Neurodegeneration. 2015;4:19.","journal-title":"Translational Neurodegeneration"},{"key":"1039_CR5","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1136\/jnnp-2012-302969","volume":"83","author":"AJ Lees","year":"2012","unstructured":"Lees AJ. The relevance of the lewy body to the pathogenesis of idiopathic parkinson\u2019s disease. J Neurol Neurosurg Psychiatry. 2012;83:954.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1039_CR6","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1080\/13880209.2019.1618344","volume":"57","author":"Z Rabiei","year":"2019","unstructured":"Rabiei Z, Solati K, Amini-Khoei H. Phytotherapy in treatment of parkinson\u2019s disease: a review. Pharm Biol. 2019;57:355\u201362.","journal-title":"Pharm Biol"},{"key":"1039_CR7","doi-asserted-by":"publisher","first-page":"119148","DOI":"10.1016\/j.ijpharm.2020.119148","volume":"579","author":"SK Bhattamisra","year":"2020","unstructured":"Bhattamisra SK, Shak AT, Xi LW, Safian NH, Choudhury H, Lim WM, Shahzad N, Alhakamy NA, Anwer MK, Radhakrishnan AK, Md S. Nose to brain delivery of rotigotine loaded Chitosan nanoparticles in human SH-SY5Y neuroblastoma cells and animal model of parkinson\u2019s disease. Int J Pharm. 2020;579:119148.","journal-title":"Int J Pharm"},{"key":"1039_CR8","doi-asserted-by":"crossref","unstructured":"Rahman MM, Wang X, Islam MR, Akash S, Supti FA, Mitu MI, Harun-Or-Rashid M, Aktar MN, Khatun Kali MS, Jahan FI, Singla RK, Shen B, Rauf A, Sharma R. Multifunctional role of natural products for the treatment of Parkinson\u2019s disease: at a glance. Front Pharmacol. 2022;13.","DOI":"10.3389\/fphar.2022.976385"},{"key":"1039_CR9","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.jconrel.2023.04.021","volume":"358","author":"P Saha","year":"2023","unstructured":"Saha P, Kathuria H, Pandey MM. Intranasal nanotherapeutics for brain targeting and clinical studies in parkinson\u2019s disease. J Controlled Release: Official J Controlled Release Soc. 2023;358:293\u2013318.","journal-title":"J Controlled Release: Official J Controlled Release Soc"},{"key":"1039_CR10","doi-asserted-by":"publisher","first-page":"148674","DOI":"10.1016\/j.brainres.2023.148674","volume":"1822","author":"DG Gadhave","year":"2024","unstructured":"Gadhave DG, Sugandhi VV, Kokare CR. Potential biomaterials and experimental animal models for inventing new drug delivery approaches in the neurodegenerative disorder: multiple sclerosis. Brain Res. 2024c;1822:148674.","journal-title":"Brain Res"},{"key":"1039_CR11","doi-asserted-by":"crossref","unstructured":"Sugandhi VV, Gadhave DG, Ugale AR, Kulkarni N, Nangare SN, Patil HP, Rath S, Saxena R, Lavate A, Patel AT. Advances in Alzheimer\u2019s therapy: Exploring neuropathological mechanisms to revolutionize the future therapeutic landscape. Ageing Res Rev. 2025;102775.","DOI":"10.1016\/j.arr.2025.102775"},{"key":"1039_CR12","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/j.1471-4159.2005.03000.x","volume":"93","author":"M Ahmad","year":"2005","unstructured":"Ahmad M, Saleem S, Ahmad AS, Yousuf S, Ansari MA, Khan MB, Ishrat T, Chaturvedi RK, Agrawal AK, Islam F. Ginkgo Biloba affords dose-dependent protection against 6\u2010hydroxydopamine\u2010induced parkinsonism in rats: neurobehavioural, neurochemical and immunohistochemical evidences. J Neurochem. 2005;93:94\u2013104.","journal-title":"J Neurochem"},{"key":"1039_CR13","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.nbd.2005.12.008","volume":"22","author":"RK Chaturvedi","year":"2006","unstructured":"Chaturvedi RK, Shukla S, Seth K, Chauhan S, Sinha C, Shukla Y, Agrawal AK. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of parkinson\u2019s disease. Neurobiol Dis. 2006;22:421\u201334.","journal-title":"Neurobiol Dis"},{"key":"1039_CR14","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.jep.2011.06.008","volume":"137","author":"L Hritcu","year":"2011","unstructured":"Hritcu L, Foyet HS, Stefan M, Mihasan M, Asongalem AE, Kamtchouing P. Neuroprotective effect of the methanolic extract of hibiscus Asper leaves in 6-hydroxydopamine-lesioned rat model of parkinson\u2019s disease. J Ethnopharmacol. 2011;137:585\u201391.","journal-title":"J Ethnopharmacol"},{"key":"1039_CR15","first-page":"83","volume":"6","author":"Y Farbood","year":"2015","unstructured":"Farbood Y, Sarkaki A, Dolatshahi M, Mansouri T, Khodadadi SM, A. Ellagic acid protects the brain against 6-Hydroxydopamine induced neuroinflammation in a rat model of parkinson\u2019s disease. Basic Clin Neurosci. 2015;6:83\u20139.","journal-title":"Basic Clin Neurosci"},{"key":"1039_CR16","doi-asserted-by":"publisher","first-page":"870","DOI":"10.3892\/ijmm.2014.1656","volume":"33","author":"M Kim","year":"2014","unstructured":"Kim M, Cho KH, Shin MS, Lee JM, Cho HS, Kim CJ, Shin DH, Yang HJ. Berberine prevents nigrostriatal dopaminergic neuronal loss and suppresses hippocampal apoptosis in mice with parkinson\u2019s disease. Int J Mol Med. 2014;33:870\u20138.","journal-title":"Int J Mol Med"},{"key":"1039_CR17","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.neuro.2013.03.004","volume":"36","author":"F Morroni","year":"2013","unstructured":"Morroni F, Tarozzi A, Sita G, Bolondi C, Zolezzi Moraga JM, Cantelli-Forti G, Hrelia P. Neuroprotective effect of Sulforaphane in 6-hydroxydopamine-lesioned mouse model of parkinson\u2019s disease. Neurotoxicology. 2013;36:63\u201371.","journal-title":"Neurotoxicology"},{"key":"1039_CR18","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.ijpharm.2017.11.023","volume":"535","author":"MA Elsheikh","year":"2018","unstructured":"Elsheikh MA, Elnaggar YS, Hamdy DA, Abdallah OY. Novel cremochylomicrons for improved oral bioavailability of the antineoplastic phytomedicine Berberine chloride: optimization and pharmacokinetics. Int J Pharm. 2018a;535:316\u201324.","journal-title":"Int J Pharm"},{"key":"1039_CR19","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s11095-017-2307-z","volume":"35","author":"MA Elsheikh","year":"2018","unstructured":"Elsheikh MA, Elnaggar YSR, Otify DY, Abdallah OY. Bioactive-Chylomicrons for oral lymphatic targeting of Berberine chloride: novel Flow-Blockage assay in Tissue-Based and Caco-2 cell line models. Pharm Res. 2018b;35:18.","journal-title":"Pharm Res"},{"key":"1039_CR20","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.biopha.2017.02.099","volume":"89","author":"X Wang","year":"2017","unstructured":"Wang X, He X, Zhang CF, Guo CR, Wang CZ, Yuan CS. Anti-arthritic effect of Berberine on adjuvant-induced rheumatoid arthritis in rats. Biomed pharmacotherapy = Biomedecine Pharmacotherapie. 2017;89:887\u201393.","journal-title":"Biomed pharmacotherapy = Biomedecine Pharmacotherapie"},{"key":"1039_CR21","doi-asserted-by":"publisher","first-page":"121523","DOI":"10.1016\/j.ijpharm.2022.121523","volume":"615","author":"PM Elhalmoushy","year":"2022","unstructured":"Elhalmoushy PM, Elsheikh MA, Matar NA, El-Hadidy WF, Kamel MA, Omran GA, Elnaggar YSR. Novel berberine-loaded hyalurosomes as a promising nanodermatological treatment for vitiligo: Biochemical, biological and gene expression studies. Int J Pharm. 2022;615:121523.","journal-title":"Int J Pharm"},{"key":"1039_CR22","doi-asserted-by":"publisher","first-page":"563","DOI":"10.2174\/1570159X16666180419141613","volume":"17","author":"D Fan","year":"2019","unstructured":"Fan D, Liu L, Wu Z, Cao M. Combating neurodegenerative diseases with the plant alkaloid berberine: molecular mechanisms and therapeutic potential. Curr Neuropharmacol. 2019;17:563\u201379.","journal-title":"Curr Neuropharmacol"},{"key":"1039_CR23","doi-asserted-by":"crossref","unstructured":"Wang Y, Tong Q, Ma SR, Zhao ZX, Pan LB, Cong L, Han P, Peng R, Yu H, Lin Y, Gao TL, Shou JW, Li XY, Zhang XF, Zhang ZW, Fu J, Wen BY, Yu JB, Cao X, Jiang JD. Oral berberine improves brain dopa\/dopamine levels to ameliorate Parkinson\u2019s disease by regulating gut microbiota. Signal Transduct Target Ther 2021;6:77.","DOI":"10.1038\/s41392-020-00456-5"},{"key":"1039_CR24","doi-asserted-by":"publisher","first-page":"618787","DOI":"10.3389\/fphar.2020.618787","volume":"11","author":"S Huang","year":"2021","unstructured":"Huang S, Liu H, Lin Y, Liu M, Li Y, Mao H, Zhang Z, Zhang Y, Ye P, Ding L. Berberine protects against NLRP3 inflammasome via ameliorating autophagic impairment in MPTP-induced parkinson\u2019s disease model. Front Pharmacol. 2021;11:618787.","journal-title":"Front Pharmacol"},{"key":"1039_CR25","doi-asserted-by":"crossref","unstructured":"Nematalla HA, Elharoun M, Bargash SN, Abd-Alhaseeb MM, Sharafeldin HA, Zewail M, Abbas H, Elsheikh MA. Novel nose-to-brain delivery of Carbenoxolone via mucoadhesive solid lipid nanoparticles for Parkinson\u2019s symptoms management: in vitro and in vivo evaluation in a rotenone-induced rat model. Int J Pharm. 2025;125197.","DOI":"10.1016\/j.ijpharm.2025.125197"},{"key":"1039_CR26","doi-asserted-by":"publisher","first-page":"960246","DOI":"10.3389\/fnagi.2022.960246","volume":"14","author":"D Arora","year":"2022","unstructured":"Arora D, Bhatt S, Kumar M, Verma R, Taneja Y, Kaushal N, Tiwari A, Tiwari V, Alexiou A, Albogami S. QbD-based Rivastigmine tartrate-loaded solid lipid nanoparticles for enhanced intranasal delivery to the brain for alzheimer\u2019s therapeutics. Front Aging Neurosci. 2022a;14:960246.","journal-title":"Front Aging Neurosci"},{"key":"1039_CR27","doi-asserted-by":"publisher","first-page":"960246","DOI":"10.3389\/fnagi.2022.960246","volume":"14","author":"D Arora","year":"2022","unstructured":"Arora D, Bhatt S, Kumar M, Verma R, Taneja Y, Kaushal N, Tiwari A, Tiwari V, Alexiou A, Albogami S, Alotaibi SS, Mittal V, Singla RK, Kaushik D, Batiha GE. QbD-based Rivastigmine tartrate-loaded solid lipid nanoparticles for enhanced intranasal delivery to the brain for alzheimer\u2019s therapeutics. Front Aging Neurosci. 2022b;14:960246.","journal-title":"Front Aging Neurosci"},{"key":"1039_CR28","doi-asserted-by":"crossref","unstructured":"Elsheikh MA, El-Feky YA, Al-Sawahli MM, Ali ME, Fayez AM, Abbas H. A Brain-targeted approach to ameliorate memory disorders in a sporadic Alzheimer\u2019s disease mouse model via intranasal luteolin-loaded nanobilosomes. Pharmaceutics. 2022:14.","DOI":"10.3390\/pharmaceutics14030576"},{"key":"1039_CR29","doi-asserted-by":"crossref","unstructured":"Elsheikh MA, El-Feky YA, Al-Sawahli MM, Ali ME, Fayez AM, Abbas H. A Brain-targeted approach to ameliorate memory disorders in a sporadic Alzheimer\u2019s disease mouse model via intranasal luteolin-loaded nanobilosomes. Pharmaceutics. 2022;14:576.","DOI":"10.3390\/pharmaceutics14030576"},{"key":"1039_CR30","doi-asserted-by":"crossref","unstructured":"Gadhave D, Quadros M, Ravula S, Ugale AR, Alkyam M, Perron JC, Gupta V. Quality by design enabled development & in-vitro assessment of a nanoemulgel formulation for nose-to-brain delivery of nintedanib for glioblastoma multiforme treatment. Int J Pharm. 2025:125632.","DOI":"10.1016\/j.ijpharm.2025.125632"},{"key":"1039_CR31","doi-asserted-by":"publisher","first-page":"142861","DOI":"10.1016\/j.ijbiomac.2025.142861","volume":"309","author":"S Khot","year":"2025","unstructured":"Khot S, Mahajan U, Jadhav A, Vaishampayan P, Bagul U, Gadhave D, Gorain B, Kokare C. Nose-to-brain delivery of sorafenib-loaded lipid-based poloxamer-carrageenan nanoemulgel: formulation and therapeutic investigation in glioblastoma-induced orthotopic rat model. Int J Biol Macromol. 2025;309:142861.","journal-title":"Int J Biol Macromol"},{"key":"1039_CR32","doi-asserted-by":"publisher","first-page":"131491","DOI":"10.1016\/j.ijbiomac.2024.131491","volume":"267","author":"DG Gadhave","year":"2024","unstructured":"Gadhave DG, Quadros M, Ugale AR, Goyal M, Ayehunie S, Gupta V. Mucoadhesive chitosan-poly (lactic-co-glycolic acid) nanoparticles for intranasal delivery of quetiapine\u2013Development & characterization in physiologically relevant 3D tissue models. Int J Biol Macromol. 2024a;267:131491.","journal-title":"Int J Biol Macromol"},{"key":"1039_CR33","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.ejps.2012.12.007","volume":"48","author":"S Md","year":"2013","unstructured":"Md S, Khan RA, Mustafa G, Chuttani K, Baboota S, Sahni JK, Ali J. Bromocriptine loaded Chitosan nanoparticles intended for direct nose to brain delivery: Pharmacodynamic, Pharmacokinetic and scintigraphy study in mice model. Eur J Pharm Sci. 2013;48:393\u2013405.","journal-title":"Eur J Pharm Sci"},{"key":"1039_CR34","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.ijpharm.2019.05.034","volume":"565","author":"HM Ezzat","year":"2019","unstructured":"Ezzat HM, Elnaggar YSR, Abdallah OY. Improved oral bioavailability of the anticancer drug Catechin using chitosomes: Design, in-vitro appraisal and in-vivo studies. Int J Pharm. 2019;565:488\u201398.","journal-title":"Int J Pharm"},{"key":"1039_CR35","doi-asserted-by":"publisher","first-page":"2853","DOI":"10.1039\/C9BM02006C","volume":"8","author":"Q-S Wang","year":"2020","unstructured":"Wang Q-S, Li K, Gao L-N, Zhang Y, Lin K-M, Cui Y-L. Intranasal delivery of Berberine via in situ thermoresponsive hydrogels with non-invasive therapy exhibits better antidepressant-like effects. Biomaterials Sci. 2020a;8:2853\u201365.","journal-title":"Biomaterials Sci"},{"key":"1039_CR36","doi-asserted-by":"publisher","first-page":"158197","DOI":"10.1016\/j.cej.2024.158197","volume":"503","author":"F Mazahir","year":"2025","unstructured":"Mazahir F, Rahi V, Kaundal RK, Alam MI, Yadav AK. Intranasal administration of berberine-loaded hydrogel ameliorates Okadaic acid-induced cognitive deficit in mice. Chem Eng J. 2025;503:158197.","journal-title":"Chem Eng J"},{"key":"1039_CR37","doi-asserted-by":"crossref","unstructured":"Sun C, Sha S, Shan Y, Gao X, Li L, Xing C, Guo Z, Du H. Intranasal delivery of BACE1 SiRNA and Berberine via engineered stem cell exosomes for the treatment of Alzheimer\u2019s disease. Int J Nanomed. 2025:5873\u201391.","DOI":"10.2147\/IJN.S506793"},{"key":"1039_CR38","doi-asserted-by":"publisher","first-page":"281","DOI":"10.3390\/ph15030281","volume":"15","author":"HA Abo El-Enin","year":"2022","unstructured":"Abo El-Enin HA, Elkomy MH, Naguib IA, Ahmed MF, Alsaidan OA, Alsalahat I, Ghoneim MM, Eid HM. Lipid nanocarriers overlaid with Chitosan for brain delivery of Berberine via the nasal route. Pharmaceuticals. 2022;15:281.","journal-title":"Pharmaceuticals"},{"key":"1039_CR39","doi-asserted-by":"crossref","unstructured":"Bahndare S, Mathure D, Ranpise H, Salunke M, Awasthi R. Surface-modified liposomal in-situ nasal gel enhances brain targeting of Berberine hydrochloride for alzheimer\u2019s therapy: optimization and in vivo studies. J Liposome Res. 2024:1\u201318.","DOI":"10.1080\/08982104.2024.2431908"},{"key":"1039_CR40","doi-asserted-by":"publisher","first-page":"3430","DOI":"10.1007\/s13197-021-04972-2","volume":"58","author":"I Katouzian","year":"2021","unstructured":"Katouzian I, Taheri RA. Preparation, characterization and release behavior of chitosan-coated nanoliposomes (chitosomes) containing Olive leaf extract optimized by response surface methodology. J Food Sci Technol. 2021;58:3430\u201343.","journal-title":"J Food Sci Technol"},{"key":"1039_CR41","doi-asserted-by":"crossref","unstructured":"Abbas H, Sayed NSE, Youssef N, Mousa PMEG, Fayez MR, Elsheikh AMMA. Novel luteolin-loaded chitosan decorated nanoparticles for brain-targeting delivery in a sporadic Alzheimer\u2019s disease mouse model: focus on antioxidant, anti-inflammatory, and amyloidogenic pathways. Pharmaceutics. 2022:14.","DOI":"10.3390\/pharmaceutics14051003"},{"key":"1039_CR42","doi-asserted-by":"publisher","first-page":"114205","DOI":"10.1016\/j.ejpb.2024.114205","volume":"196","author":"WA El-Dakroury","year":"2024","unstructured":"El-Dakroury WA, Zewail MB, Asaad GF, Abdallah HMI, Shabana ME, Said AR, Doghish AS, Azab HA, Amer DH, Hassan AE, Sayed AS, Samra GM, Sallam A-AM. Fexofenadine-loaded Chitosan coated solid lipid nanoparticles (SLNs): A potential oral therapy for ulcerative colitis. Eur J Pharm Biopharm. 2024;196:114205.","journal-title":"Eur J Pharm Biopharm"},{"key":"1039_CR43","first-page":"100170","volume":"5","author":"MA Elsheikh","year":"2023","unstructured":"Elsheikh MA, Gaafar PME, Khattab MA, MK AH, Noureldin MH, Abbas H. Dual-effects of caffeinated hyalurosomes as a nano-cosmeceutical gel counteracting UV-induced skin ageing. Int J Pharmaceutics: X. 2023;5:100170.","journal-title":"Int J Pharmaceutics: X"},{"key":"1039_CR44","doi-asserted-by":"crossref","unstructured":"Zewail M, Elsheikh MA, Abbas H, Gaafar PM. Unveiling the synergistic impact of cocktail nanohyalurosomes encapsulating Berberine and dexamethasone in managing rheumatoid arthritis: in-vitro evaluation and biological studies. J Microencapsul. 2025:1\u201316.","DOI":"10.1080\/02652048.2025.2498963"},{"key":"1039_CR45","doi-asserted-by":"crossref","unstructured":"Swamy G, Holla R, Rao S. Establishing the rotenone-induced Parkinson\u2019s disease animal model in wistar albino rats. J Health Allied Sci NU. 2021:11.","DOI":"10.1055\/s-0041-1726690"},{"key":"1039_CR46","doi-asserted-by":"crossref","unstructured":"Hanson LR, Fine JM, Svitak AL, Faltesek KA. Intranasal administration of CNS therapeutics to awake mice. J Vis Exp: JoVE. 2013:4440.","DOI":"10.3791\/4440-v"},{"key":"1039_CR47","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.brainres.2016.11.020","volume":"1655","author":"ZN Zhang","year":"2017","unstructured":"Zhang ZN, Zhang JS, Xiang J, Yu ZH, Zhang W, Cai M, Li XT, Wu T, Li WW, Cai DF. Subcutaneous rotenone rat model of parkinson\u2019s disease: dose exploration study. Brain Res. 2017;1655:104\u201313.","journal-title":"Brain Res"},{"key":"1039_CR48","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1007\/s12272-013-0051-4","volume":"36","author":"KS Shin","year":"2013","unstructured":"Shin KS, Choi HS, Zhao TT, Suh KH, Kwon IH, Choi SO, Lee MK. Neurotoxic effects of Berberine on long-term L-DOPA administration in 6-hydroxydopamine-lesioned rat model of parkinson\u2019s disease. Arch Pharm Res. 2013;36:759\u201367.","journal-title":"Arch Pharm Res"},{"key":"1039_CR49","doi-asserted-by":"crossref","unstructured":"Abu-Elfotuh K, Hamdan AME, Mohammed AA, Atwa AM, Kozman MR, Ibrahim AM, Motawea SM, Selim H, Tohamy STK, Nour El-Din M, Zaghlool SS, Gowifel AMH, Awny MM. Neuroprotective effects of some nutraceuticals against manganese-induced Parkinson\u2019s disease in rats: possible modulatory effects on TLR4\/NLRP3\/NF-\u03baB, GSK-3\u03b2, Nrf2\/HO-1, and apoptotic pathways. Pharmaceuticals (Basel, Switzerland). 2022:15.","DOI":"10.3390\/ph15121554"},{"key":"1039_CR50","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3389\/fnbeh.2013.00175","volume":"7","author":"FL Campos","year":"2013","unstructured":"Campos FL, Carvalho MM, Cristov\u00e3o AC, Je G, Baltazar G, Salgado AJ, Kim YS, Sousa N. Rodent models of parkinson\u2019s disease: beyond the motor symptomatology. Front Behav Neurosci. 2013;7:175.","journal-title":"Front Behav Neurosci"},{"key":"1039_CR51","doi-asserted-by":"crossref","unstructured":"Huang L, Xiao D, Sun H, Qu Y, Su X. Behavioral tests for evaluating the characteristics of brain diseases in rodent models: optimal choices for improved outcomes (Review). Mol Med Rep. 2022:25.","DOI":"10.3892\/mmr.2022.12699"},{"key":"1039_CR52","doi-asserted-by":"crossref","unstructured":"Carter RJ, Morton J, Dunnett SB. Motor coordination and balance in rodents. Curr Protocols Neurosci. 2001:Chap. 8, Unit 8.12.","DOI":"10.1002\/0471142301.ns0812s15"},{"key":"1039_CR53","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1177\/0960327117745694","volume":"37","author":"A Fouad","year":"2018","unstructured":"Fouad A, Al-Melhim W. Vanillin mitigates the adverse impact of cisplatin and methotrexate on rat kidneys. Hum Exp Toxicol. 2018;37:937\u201343.","journal-title":"Hum Exp Toxicol"},{"key":"1039_CR54","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1080\/08982104.2016.1275679","volume":"28","author":"H Abd-El-Azim","year":"2018","unstructured":"Abd-El-Azim H, Ramadan A, Nafee N, Khalafallah N. Entrapment efficiency of pyridoxine hydrochloride in unilamellar liposomes: experimental versus model-generated data. J Liposome Res. 2018;28:112\u20136.","journal-title":"J Liposome Res"},{"key":"1039_CR55","doi-asserted-by":"crossref","unstructured":"Gaafar PM, Abbas H, Aboukilila HY, Kamal MF, Zewail M. L-carnosine-loaded hya-ascorposomes attenuate UVB-induced skin photoaging: formulation, in vitro and in vivo evaluation. Int J Pharm. 2025:125895.","DOI":"10.1016\/j.ijpharm.2025.125895"},{"key":"1039_CR56","doi-asserted-by":"crossref","unstructured":"Alshraim MO, Sangi S, Harisa GI, Alomrani AH, Yusuf O, Badran MM. Chitosan-coated flexible liposomes magnify the anticancer activity and bioavailability of docetaxel: impact on composition. Molecules (Basel, Switzerland). 2019:24.","DOI":"10.3390\/molecules24020250"},{"key":"1039_CR57","first-page":"65","volume":"2622","author":"G Du","year":"2023","unstructured":"Du G, Sun X. Ethanol injection method for liposome Preparation. methods in molecular biology. (Clifton N J). 2023;2622:65\u201370.","journal-title":"(Clifton N J)"},{"key":"1039_CR58","doi-asserted-by":"crossref","unstructured":"Morilla MJ, Romero EL. Ultradeformable phospholipid vesicles as a drug delivery system: a review. Res Rep Transderm Drug Deliv. 2015;4:55\u201369","DOI":"10.2147\/RRTD.S50370"},{"key":"1039_CR59","doi-asserted-by":"crossref","unstructured":"Abbas H, Gad HA, El Sayed NS, Rashed LA, Khattab MA, Noor AO, Zewail M. Development and evaluation of novel leflunomide SPION bioemulsomes for the intra-articular treatment of arthritis. Pharmaceutics. 2022;14:2005.","DOI":"10.3390\/pharmaceutics14102005"},{"key":"1039_CR60","first-page":"100332","volume":"6","author":"G Nerli","year":"2023","unstructured":"Nerli G, Robla S, Bartalesi M, Luceri C, D\u2019Ambrosio M, Csaba N, Maestrelli F. Chitosan coated niosomes for nose-to-brain delivery of clonazepam: formulation, stability and permeability studies. Carbohydr Polym Technol Appl. 2023;6:100332.","journal-title":"Carbohydr Polym Technol Appl"},{"key":"1039_CR61","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1021\/mp200572t","volume":"9","author":"K Sonaje","year":"2012","unstructured":"Sonaje K, Chuang E-Y, Lin K-J, Yen T-C, Su F-Y, Tseng MT, Sung H-W. Opening of epithelial tight junctions and enhancement of paracellular permeation by chitosan: microscopic, ultrastructural, and computed-tomographic observations. Mol Pharm. 2012;9:1271\u20139.","journal-title":"Mol Pharm"},{"key":"1039_CR62","doi-asserted-by":"publisher","first-page":"134073","DOI":"10.1016\/j.colsurfa.2024.134073","volume":"693","author":"EA Vasilieva","year":"2024","unstructured":"Vasilieva EA, Valeeva FG, Babkin RA, Amerhanova SK, Voloshina AD, Nizameev IR, Zakharov VM, Valeeva DN, Zueva IV, Petrov KA. Design of glycol chitosan-decorated liposomes for the intranasal delivery of hydrophilic substances: physicochemical and in vitro\/in vivo biological assessment. Colloids Surf A. 2024;693:134073.","journal-title":"Colloids Surf A"},{"key":"1039_CR63","doi-asserted-by":"publisher","first-page":"170","DOI":"10.3390\/pharmaceutics14010170","volume":"14","author":"M Guerini","year":"2022","unstructured":"Guerini M, Condr\u00f2 G, Perugini P. Evaluation of the mucoadhesive properties of chitosan-based microstructured lipid carrier (CH-MLC). Pharmaceutics. 2022;14:170.","journal-title":"Pharmaceutics"},{"key":"1039_CR64","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.3390\/pharmaceutics13081197","volume":"13","author":"DS Panda","year":"2021","unstructured":"Panda DS, Eid HM, Elkomy MH, Khames A, Hassan RM, El-Ela A, Yassin FI, H.A. Berberine encapsulated lecithin\u2013chitosan nanoparticles as innovative wound healing agent in type II diabetes. Pharmaceutics. 2021;13:1197.","journal-title":"Pharmaceutics"},{"key":"1039_CR65","doi-asserted-by":"publisher","first-page":"7149","DOI":"10.1039\/C4TB00876F","volume":"2","author":"TX Nguyen","year":"2014","unstructured":"Nguyen TX, Huang L, Liu L, Abdalla AME, Gauthier M, Yang G. Chitosan-coated nano-liposomes for the oral delivery of Berberine hydrochloride. J Mater Chem B. 2014;2:7149\u201359.","journal-title":"J Mater Chem B"},{"key":"1039_CR66","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.3390\/pharmaceutics14051003","volume":"14","author":"H Abbas","year":"2022","unstructured":"Abbas H, Sayed NSE, Youssef NAHA, Gaafar ME, Mousa P, Fayez MR, Elsheikh AM, M.A. Novel luteolin-loaded Chitosan decorated nanoparticles for brain-targeting delivery in a sporadic alzheimer\u2019s disease mouse model: focus on antioxidant, anti-inflammatory, and amyloidogenic pathways. Pharmaceutics. 2022c;14:1003.","journal-title":"Pharmaceutics"},{"key":"1039_CR67","doi-asserted-by":"publisher","first-page":"9902","DOI":"10.3390\/ijms24129902","volume":"24","author":"C Moya-Garcia","year":"2023","unstructured":"Moya-Garcia C, Li-Jessen N, Tabrizian M. Chitosomes loaded with docetaxel as a promising drug delivery system to laryngeal cancer cells: an in vitro cytotoxic study. Int J Mol Sci. 2023;24:9902.","journal-title":"Int J Mol Sci"},{"key":"1039_CR68","doi-asserted-by":"publisher","first-page":"123334","DOI":"10.1016\/j.ijpharm.2023.123334","volume":"644","author":"H Abd-El-Azim","year":"2023","unstructured":"Abd-El-Azim H, Abbas H, El Sayed NS, Fayez AM, Zewail M. Non-invasive management of rheumatoid arthritis using Hollow microneedles as a tool for transdermal delivery of Teriflunomide loaded solid lipid nanoparticles. Int J Pharm. 2023;644:123334.","journal-title":"Int J Pharm"},{"key":"1039_CR69","doi-asserted-by":"publisher","first-page":"100142","DOI":"10.1016\/j.fhfh.2023.100142","volume":"4","author":"JM Joy","year":"2023","unstructured":"Joy JM, Dara PAMRJ, Renuka PK, Anandan V, R. Liposome mediated encapsulation and role of Chitosan on modulating liposomal stability to deliver potential bioactives-A review. Food Hydrocoll Health. 2023;4:100142.","journal-title":"Food Hydrocoll Health"},{"key":"1039_CR70","first-page":"1934578X2513845","volume":"20","author":"AM Metwaly","year":"2025","unstructured":"Metwaly AM, Abd-El-Azim H, Zewail M, Alsfouk AA, Elkaeed EB, Elkady H, Eissa IH. Exploring the anticancer potential of chitosome-encapsulated theobromine analogue: integrated computational, physiochemical and in vitro study. Nat Prod Commun. 2025;20:1934578X251384515.","journal-title":"Nat Prod Commun"},{"key":"1039_CR71","volume-title":"Chitosan-Coating effect on the characteristics of liposomes: A focus on bioactive compounds","author":"C Sebaaly","year":"2021","unstructured":"Sebaaly C, Trifan A, Sieniawska E, Greige-Gerges HJP. Chitosan-Coating effect on the characteristics of liposomes: A focus on bioactive compounds. and Essential Oils: A Review; 2021b."},{"key":"1039_CR72","doi-asserted-by":"crossref","unstructured":"Metwaly AM, Abd-El-Azim H, Zewail M, Alsfouk AA, Elkaeed EB, Eissa IH. Chitosomal encapsulation enhances the anticancer efficacy of a theobromine analogue: an integrated in Silico and in vitro study. J Comput Biophy Chem. 2024.","DOI":"10.1142\/S2737416524500716"},{"key":"1039_CR73","doi-asserted-by":"publisher","first-page":"445","DOI":"10.3390\/pr9030445","volume":"9","author":"C Sebaaly","year":"2021","unstructured":"Sebaaly C, Trifan A, Sieniawska E, Greige-Gerges H. Chitosan-coating effect on the characteristics of liposomes: A focus on bioactive compounds and essential oils: A review. Processes. 2021a;9:445.","journal-title":"Processes"},{"key":"1039_CR74","doi-asserted-by":"publisher","first-page":"116033","DOI":"10.1016\/j.lwt.2024.116033","volume":"198","author":"X Zhang","year":"2024","unstructured":"Zhang X, Wu Z, Zhang W, Wang L, Zhao P, Lv X, Guo P, Chen J. Surface modification by Chitosan for improving stability and antioxidative activity of astaxanthin-loaded liposomes. Lwt. 2024;198:116033.","journal-title":"Lwt"},{"key":"1039_CR75","doi-asserted-by":"publisher","first-page":"121939","DOI":"10.1016\/j.ijpharm.2022.121939","volume":"623","author":"M Zewail","year":"2022","unstructured":"Zewail M, El-Deeb NM, Mousa MR, Abbas H. Hyaluronic acid coated Teriflunomide (A771726) loaded lipid carriers for the oral management of rheumatoid arthritis. Int J Pharm. 2022;623:121939.","journal-title":"Int J Pharm"},{"key":"1039_CR76","first-page":"4","volume":"3","author":"A Yadav","year":"2010","unstructured":"Yadav A, Shete A, Gavane Y, Dabke A, Kulkarni P, Sakhare S. Chitosomes: A novel drug delivery system. Res J Pharm Technol. 2010;3:4\u201312.","journal-title":"Res J Pharm Technol"},{"key":"1039_CR77","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3109\/10717544.2011.621994","volume":"19","author":"N Li","year":"2012","unstructured":"Li N, Zhuang CY, Wang M, Sui CG, Pan WS. Low molecular weight chitosan-coated liposomes for ocular drug delivery: in vitro and in vivo studies. Drug Delivery. 2012;19:28\u201335.","journal-title":"Drug Delivery"},{"key":"1039_CR78","doi-asserted-by":"publisher","first-page":"121244","DOI":"10.1016\/j.ijpharm.2021.121244","volume":"610","author":"H Abbas","year":"2021","unstructured":"Abbas H, Refai H, El Sayed N, Rashed LA, Mousa MR, Zewail M. Superparamagnetic iron oxide loaded Chitosan coated bilosomes for magnetic nose to brain targeting of Resveratrol. Int J Pharm. 2021;610:121244.","journal-title":"Int J Pharm"},{"key":"1039_CR79","doi-asserted-by":"crossref","unstructured":"Chen M, Amerigos JCK, Su Z, Guissi NEI, Xiao Y, Zong L, Ping Q. Folate receptor-targeting and reactive oxygen species-responsive liposomal formulation of methotrexate for treatment of rheumatoid arthritis. Pharmaceutics. 2019:11.","DOI":"10.3390\/pharmaceutics11110582"},{"key":"1039_CR80","doi-asserted-by":"crossref","unstructured":"Makled S, Abbas H, Ali ME, Zewail M. Melatonin hyalurosomes in collagen thermosensitive gel as a potential repurposing approach for rheumatoid arthritis management via the intra-articular route. Int J Pharm. 2024:124449.","DOI":"10.1016\/j.ijpharm.2024.124449"},{"key":"1039_CR81","doi-asserted-by":"publisher","first-page":"118447","DOI":"10.1016\/j.ijpharm.2019.118447","volume":"567","author":"M Zewail","year":"2019","unstructured":"Zewail M, Nafee N, Helmy MW, Boraie N. Coated nanostructured lipid carriers targeting the joints\u2013an effective and safe approach for the oral management of rheumatoid arthritis. Int J Pharm. 2019;567:118447.","journal-title":"Int J Pharm"},{"key":"1039_CR82","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1007\/s13346-021-00992-9","volume":"11","author":"M Zewail","year":"2021","unstructured":"Zewail M, Nafee N, Helmy MW, Boraie N. Synergistic and receptor-mediated targeting of arthritic joints via intra-articular injectable smart hydrogels containing leflunomide-loaded lipid nanocarriers. Drug Delivery Translational Res. 2021;11:2496\u2013519.","journal-title":"Drug Delivery Translational Res"},{"key":"1039_CR83","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3390\/md13010141","volume":"13","author":"MF Queiroz","year":"2014","unstructured":"Queiroz MF, Melo T, Sabry KR, Sassaki DA, Rocha GL, H.A.O. Does the use of Chitosan contribute to oxalate kidney stone formation? Mar Drugs. 2014;13:141\u201358.","journal-title":"Mar Drugs"},{"key":"1039_CR84","doi-asserted-by":"publisher","first-page":"5027","DOI":"10.1039\/c2sm07236j","volume":"8","author":"P-L Lam","year":"2012","unstructured":"Lam P-L, Lee KK-H, Kok SH-L, Cheng GY-M, Tao X-M, Hau DK-P, Yuen MC-W, Lam K-H, Gambari R, Chui C-H. Development of formaldehyde-free agar\/gelatin microcapsules containing Berberine HCl and Gallic acid and their topical and oral applications. Soft Matter. 2012;8:5027\u201337.","journal-title":"Soft Matter"},{"key":"1039_CR85","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1208\/s12249-010-9520-y","volume":"11","author":"SK Battu","year":"2010","unstructured":"Battu SK, Repka MA, Maddineni S, Chittiboyina AG, Avery MA, Majumdar S. Physicochemical characterization of Berberine chloride: a perspective in the development of a solution dosage form for oral delivery. AAPS PharmSciTech. 2010;11:1466\u201375.","journal-title":"AAPS PharmSciTech"},{"key":"1039_CR86","doi-asserted-by":"publisher","first-page":"45290","DOI":"10.1039\/C6RA05574E","volume":"6","author":"M Hasan","year":"2016","unstructured":"Hasan M, Messaoud GB, Michaux F, Tamayol A, Kahn CJ, Belhaj N, Linder M, Arab-Tehrany E. Chitosan-coated liposomes encapsulating curcumin: study of lipid\u2013polysaccharide interactions and nanovesicle behavior. RSC Adv. 2016;6:45290\u2013304.","journal-title":"RSC Adv"},{"key":"1039_CR87","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1007\/s00249-009-0524-z","volume":"38","author":"MM Mady","year":"2009","unstructured":"Mady MM, Darwish MM, Khalil S, Khalil WM. Biophysical studies on chitosan-coated liposomes. Eur Biophys J. 2009;38:1127\u201333.","journal-title":"Eur Biophys J"},{"key":"1039_CR88","doi-asserted-by":"crossref","unstructured":"Gharanjig H, Gharanjig K, Hosseinnezhad M, Jafari SM. Differential scanning calorimetry (DSC) of nanoencapsulated food ingredients, characterization of nanoencapsulated food ingredients. Elsevier; 2020. pp. 295\u2013346.","DOI":"10.1016\/B978-0-12-815667-4.00010-9"},{"key":"1039_CR89","doi-asserted-by":"crossref","unstructured":"Freag MS, Elnaggar YS, Abdallah OY. Lyophilized phytosomal nanocarriers as platforms for enhanced diosmin delivery: optimization and ex vivo permeation. Int J Nanomed. 2013:2385\u201397.","DOI":"10.2147\/IJN.S45231"},{"key":"1039_CR90","first-page":"100474","volume":"7","author":"M Mehra","year":"2024","unstructured":"Mehra M, Sheorain J, Bakshi J, Thakur R, Grewal S, Dhingra D, Kumari S. Synthesis and evaluation of Berberine loaded Chitosan nanocarrier for enhanced in-vitro antioxidant and anti-inflammatory potential. Carbohydr Polym Technol Appl. 2024;7:100474.","journal-title":"Carbohydr Polym Technol Appl"},{"key":"1039_CR91","doi-asserted-by":"publisher","first-page":"132737","DOI":"10.1016\/j.ijbiomac.2024.132737","volume":"273","author":"R Solanki","year":"2024","unstructured":"Solanki R, Parmar B, Jadav M, Pooja D, Kulhari H, Patel S. Berberine encapsulated Phenylboronic acid-conjugated Pullulan nanoparticles: Synthesis, characterization and anticancer activity validated in A431 skin cancer cells and 3D spheroids. Int J Biol Macromol. 2024;273:132737.","journal-title":"Int J Biol Macromol"},{"key":"1039_CR92","doi-asserted-by":"crossref","unstructured":"Magrinelli F, Picelli A, Tocco P, Federico A, Roncari L, Smania N, Zanette G, Tamburin S. Pathophysiology of motor dysfunction in Parkinson\u2019s disease as the rationale for drug treatment and rehabilitation. Parkinson\u2019s disease. 2016:9832839.","DOI":"10.1155\/2016\/9832839"},{"key":"1039_CR93","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s12640-021-00451-w","volume":"40","author":"CN Chen","year":"2022","unstructured":"Chen CN, Wang MH, Soung HS, Chen SM, Fang CH, Lin YW, Tseng HC. (L)-Theanine ameliorated Rotenone-Induced Parkinsonism-like symptoms in rats. Neurotox Res. 2022;40:241\u201358.","journal-title":"Neurotox Res"},{"key":"1039_CR94","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12906-019-2738-7","volume":"20","author":"T Wang","year":"2020","unstructured":"Wang T, Li C, Han B, Wang Z, Meng X, Zhang L, He J, Fu F. Neuroprotective effects of Danshensu on rotenone-induced parkinson\u2019s disease models in vitro and in vivo. BMC Complement Med Ther. 2020b;20:20.","journal-title":"BMC Complement Med Ther"},{"key":"1039_CR95","doi-asserted-by":"crossref","unstructured":"Sala G, Arosio A, Stefanoni G, Melchionda L, Riva C, Marinig D, Brighina L, Ferrarese C. Rotenone upregulates alpha-synuclein and myocyte enhancer factor 2D independently from lysosomal degradation inhibition. BioMed Res Int. 2013:846725.","DOI":"10.1155\/2013\/846725"},{"key":"1039_CR96","doi-asserted-by":"publisher","first-page":"8366","DOI":"10.1039\/D1FO01360B","volume":"12","author":"H Deng","year":"2021","unstructured":"Deng H, Ma Z. Protective effects of Berberine against MPTP-induced dopaminergic neuron injury through promoting autophagy in mice. Food Funct. 2021;12:8366\u201375.","journal-title":"Food Funct"},{"key":"1039_CR97","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.neulet.2014.01.014","volume":"565","author":"AM Colangelo","year":"2014","unstructured":"Colangelo AM, Alberghina L, Papa M. Astrogliosis as a therapeutic target for neurodegenerative diseases. Neurosci Lett. 2014;565:59\u201364.","journal-title":"Neurosci Lett"},{"key":"1039_CR98","doi-asserted-by":"crossref","unstructured":"Prunell G, Olivera-Bravo S. A focus on astrocyte contribution to Parkinson\u2019s disease etiology. Biomolecules. 2022:12.","DOI":"10.3390\/biom12121745"},{"key":"1039_CR99","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.nbd.2015.06.010","volume":"82","author":"J Tong","year":"2015","unstructured":"Tong J, Ang L-C, Williams B, Furukawa Y, Fitzmaurice P, Guttman M, Boileau I, Hornykiewicz O, Kish SJ. Low levels of astroglial markers in parkinson\u2019s disease: relationship to \u03b1-synuclein accumulation. Neurobiol Dis. 2015;82:243\u201353.","journal-title":"Neurobiol Dis"},{"key":"1039_CR100","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s40035-021-00265-y","volume":"10","author":"C Wang","year":"2021","unstructured":"Wang C, Yang T, Liang M, Xie J, Song N. Astrocyte dysfunction in parkinson\u2019s disease: from the perspectives of transmitted \u03b1-synuclein and genetic modulation. Translational Neurodegeneration. 2021a;10:39.","journal-title":"Translational Neurodegeneration"},{"key":"1039_CR101","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.drudis.2018.01.011","volume":"23","author":"K Gorshkov","year":"2018","unstructured":"Gorshkov K, Aguisanda F, Thorne N, Zheng W. Astrocytes as targets for drug discovery. Drug Discovery Today. 2018;23:673\u201380.","journal-title":"Drug Discovery Today"},{"key":"1039_CR102","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1111\/cns.13805","volume":"28","author":"H Fikry","year":"2022","unstructured":"Fikry H, Saleh LA, Abdel Gawad S. Neuroprotective effects of Curcumin on the cerebellum in a rotenone-induced parkinson\u2019s disease model. CNS Neurosci Ther. 2022;28:732\u201348.","journal-title":"CNS Neurosci Ther"},{"key":"1039_CR103","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s10059-013-2298-5","volume":"35","author":"J Bae","year":"2013","unstructured":"Bae J, Lee D, Kim YK, Gil M, Lee JY, Lee KJ. Berberine protects 6-hydroxydopamine-induced human dopaminergic neuronal cell death through the induction of Heme oxygenase-1. Mol Cells. 2013;35:151\u20137.","journal-title":"Mol Cells"},{"key":"1039_CR104","doi-asserted-by":"publisher","first-page":"919233","DOI":"10.3389\/fphar.2022.919233","volume":"13","author":"XX Yang","year":"2022","unstructured":"Yang XX, Yang R, Zhang F. Role of Nrf2 in parkinson\u2019s disease: toward new perspectives. Front Pharmacol. 2022;13:919233.","journal-title":"Front Pharmacol"},{"key":"1039_CR105","doi-asserted-by":"publisher","first-page":"100209","DOI":"10.1016\/j.prmcm.2022.100209","volume":"6","author":"S Kumar","year":"2023","unstructured":"Kumar S, Kumar S, Arthur R, Kumar P. Trans-cinnamaldehyde mitigates rotenone-induced neurotoxicity via inhibiting oxidative stress in rats. Pharmacol Res - Mod Chin Med. 2023;6:100209.","journal-title":"Pharmacol Res - Mod Chin Med"},{"key":"1039_CR106","doi-asserted-by":"publisher","first-page":"32206","DOI":"10.1038\/srep32206","volume":"6","author":"Q Zhou","year":"2016","unstructured":"Zhou Q, Chen B, Wang X, Wu L, Yang Y, Cheng X, Hu Z, Cai X, Yang J, Sun X, Lu W, Yan H, Chen J, Ye J, Shen J, Cao P. Sulforaphane protects against rotenone-induced neurotoxicity in vivo: involvement of the mTOR, Nrf2, and autophagy pathways. Sci Rep. 2016;6:32206.","journal-title":"Sci Rep"},{"key":"1039_CR107","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1089\/ars.2012.5116","volume":"20","author":"C Mo","year":"2014","unstructured":"Mo C, Wang L, Zhang J, Numazawa S, Tang H, Tang X, Han X, Li J, Yang M, Wang Z, Wei D, Xiao H. The crosstalk between Nrf2 and AMPK signal pathways is important for the anti-inflammatory effect of Berberine in LPS-stimulated macrophages and endotoxin-shocked mice. Antioxid Redox Signal. 2014;20:574\u201388.","journal-title":"Antioxid Redox Signal"},{"key":"1039_CR108","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1080\/13510002.2016.1140406","volume":"22","author":"P Hasanein","year":"2017","unstructured":"Hasanein P, Ghafari-Vahed M, Khodadadi I. Effects of isoquinoline alkaloid Berberine on lipid peroxidation, antioxidant defense system, and liver damage induced by lead acetate in rats. Redox Report: Commun Free Radical Res. 2017;22:42\u201350.","journal-title":"Redox Report: Commun Free Radical Res"},{"key":"1039_CR109","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1007\/s12264-023-01023-y","volume":"39","author":"QQ Han","year":"2023","unstructured":"Han QQ, Le W. NLRP3 Inflammasome-Mediated neuroinflammation and related mitochondrial impairment in parkinson\u2019s disease. Neurosci Bull. 2023;39:832\u201344.","journal-title":"Neurosci Bull"},{"key":"1039_CR110","doi-asserted-by":"publisher","first-page":"14042","DOI":"10.1096\/fj.202001328R","volume":"34","author":"H Che","year":"2020","unstructured":"Che H, Li H, Li Y, Wang YQ, Yang ZY, Wang RL, Wang LH. Melatonin exerts neuroprotective effects by inhibiting neuronal pyroptosis and autophagy in STZ-induced diabetic mice. FASEB J. 2020;34:14042\u201354.","journal-title":"FASEB J"},{"key":"1039_CR111","doi-asserted-by":"crossref","unstructured":"Zou L, Che Z, Ding K, Zhang C, Liu X, Wang L, Li A, Zhou J. JAC4 Alleviates rotenone-induced Parkinson\u2019s disease through the inactivation of the NLRP3 signal pathway. Antioxidants (Basel, Switzerland). 2023:12.","DOI":"10.3390\/antiox12051134"},{"key":"1039_CR112","doi-asserted-by":"publisher","first-page":"154131","DOI":"10.1016\/j.phymed.2022.154131","volume":"101","author":"L Dai","year":"2022","unstructured":"Dai L, Zhu L, Ma S, Liu J, Zhang M, Li J, Luo Y, Zhou X, Chen Q, Wang L, Huang Y, Chen Y. Berberine alleviates NLRP3 inflammasome induced endothelial junction dysfunction through Ca(2+) signalling in inflammatory vascular injury. Phytomedicine: Int J Phytotherapy Phytopharmacology. 2022;101:154131.","journal-title":"Phytomedicine: Int J Phytotherapy Phytopharmacology"},{"key":"1039_CR113","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s11010-013-1781-9","volume":"384","author":"MA Siddiqui","year":"2013","unstructured":"Siddiqui MA, Ahmad J, Farshori NN, Saquib Q, Jahan S, Kashyap MP, Ahamed M, Musarrat J, Al-Khedhairy AA. Rotenone-induced oxidative stress and apoptosis in human liver HepG2 cells. Mol Cell Biochem. 2013;384:59\u201369.","journal-title":"Mol Cell Biochem"},{"key":"1039_CR114","first-page":"2008","volume":"16","author":"H Zheng","year":"2018","unstructured":"Zheng H, Lan J, Li J, Lv L. Therapeutic effect of Berberine on renal ischemia-reperfusion injury in rats and its effect on Bax and Bcl-2. Experimental Therapeutic Med. 2018;16:2008\u201312.","journal-title":"Experimental Therapeutic Med"}],"container-title":["BMC Pharmacology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-025-01039-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40360-025-01039-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-025-01039-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T16:02:21Z","timestamp":1765296141000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpharmacoltoxicol.biomedcentral.com\/articles\/10.1186\/s40360-025-01039-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,9]]},"references-count":114,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1039"],"URL":"https:\/\/doi.org\/10.1186\/s40360-025-01039-2","relation":{},"ISSN":["2050-6511"],"issn-type":[{"value":"2050-6511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,9]]},"assertion":[{"value":"15 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments followed the ARRIVE guidelines and adhered to the U.K. Animals (Scientific Procedures) Act, 1986, and the National Research Council\u2019s Guide for the Care and Use of Laboratory Animals, which has been approved by the Research Ethics Committee at Damanhour University (Ref. No. 124PO39).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"209"}}